ProMIS Neurosciences Announces Fiscal Year 2019 Annual Results
TORONTO and CAMBRIDGE, Mass., March 18, 2020 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF) (“ProMIS or the Company”), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic …